US pharmaceutical company faces SEC probe
The California-based Adamis Pharmaceuticals Corporation says it is under investigation by the US securities regulator – in addition to Manhattan federal prosecutors – over the sale of veterinary products.
To read more
Subscribe to Global Investigations Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Investigations Review experts.